Status:
UNKNOWN
Correlation Between TCM Syndrome Factors and TSH Changes of Thyroid Hormone Withdrawal Before Iodine Therapy in Postoperative Patients With Thyroid Cancer
Lead Sponsor:
Qianfoshan Hospital
Conditions:
Differentiated Thyroid Carcinoma
TCM Syndrome Type
Eligibility:
All Genders
18-75 years
Brief Summary
The purpose of this study is to make a dialectical classification of patients who will receive 131I treatment after operation of thyroid cancer from the point of view of dialectics of syndrome element...
Detailed Description
Thyroid cancer is a common thyroid tumor. In the past few decades, the incidence of thyroid cancer in most parts of the world has increased steadily year by year. At present, the best treatment for di...
Eligibility Criteria
Inclusion
- Study time: June 1, 2021, to January 1, 2022;
- Study site: The First Affiliated Hospital of Shandong First Medical University;
- 18-75 years old (including upper and lower limits), male or female;
- Patients with differentiated thyroid carcinoma diagnosed pathologically after total thyroidectomy
- Patients with oral levothyroxine tablets ≥ 4 weeks after operation
- Patients who have stopped taking levothyroxine tablets and whose TSH \< 4.2uIU/ml at the time of withdrawal
- Patients who meet the 131I treatment criteria
Exclusion
- Pregnant or lactating women
- Patients with various mental disorders, unconscious, etc.
- Cases with inaccurate information collection
Key Trial Info
Start Date :
June 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04916262
Start Date
June 20 2021
End Date
January 1 2022
Last Update
June 16 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.